Guardion Health Sciences

GHSI52

Penny Stock

$3.25arrow_drop_up0.30%$0.01

Penny Stock

GHSI52

$3.25

arrow_drop_up0.30%$0.01

Penny Stock

Performance History

Key Stats
Open	$3.27
Prev. Close	$3.26
EPS	-4.11
Dividend	-
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$4.34M
PE Ratio	-

	LOW	HIGH
Day Range	3.22	3.28
52 Week Range	3.04	18.00

Ratios

Revenue	-





EPS	-4.11

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Guardion Health Sciences (GHSI)

Guardion Health Sciences Inc. (GHSI) is a company that specializes in the development and commercialization of technologies and products to improve vision performance. The company focuses on the ocular health marketplace and offers a range of solutions for both vision testing and vision improvement. With a commitment to innovation and customer satisfaction, Guardion has established itself as a leader in the field.

One of Guardion's key offerings is the patented MapcatSF test, which assesses macular pigment optical density (MPOD). This test helps determine the risk of developing age-related macular degeneration (AMD), the leading cause of vision loss in seniors. By identifying individuals at risk, Guardion's products can help prevent or delay the progression of the disease.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Ms. Janet Hall
Headquarters: Houston
Employees: 12
Exchange: NASDAQ

add Guardion Health Sciences to watchlist

Keep an eye on Guardion Health Sciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Guardion Health Sciences 's (GHSI) price per share?

The current price per share for Guardion Health Sciences (GHSI) is $3.25. The stock has seen a price change of $0.01 recently, indicating a 0.31% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Guardion Health Sciences (GHSI)?

For Guardion Health Sciences (GHSI), the 52-week high is $18, which is 453.85% from the current price. The 52-week low is $3.04, the current price is 6.91% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Guardion Health Sciences (GHSI) a growth stock?

Guardion Health Sciences (GHSI) has shown an average price growth of -6.03% over the past three years. It has received a score of 4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Guardion Health Sciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Guardion Health Sciences (GHSI) stock price performance year to date (YTD)?

As of the latest data, Guardion Health Sciences (GHSI) has a year-to-date price change of -40.69%. Over the past month, the stock has experienced a price change of -0.91%. Over the last three months, the change has been -71.24%. Over the past six months, the figure is -64.29%. Looking at a longer horizon, the five-year price change stands at -94.98%.

help

Is Guardion Health Sciences (GHSI) a profitable company?

Guardion Health Sciences (GHSI) has a net income of $158.03K, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 44.04% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.88K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 10.85%, providing insight into the company's sales performance and growth. The gross profit is $5.39M. Operating income is noted at -$4.34M. Furthermore, the EBITDA is -$3.56M.

help

What is the market capitalization of Guardion Health Sciences (GHSI)?

Guardion Health Sciences (GHSI) has a market capitalization of $4.35M. The average daily trading volume is 3.26, indicating the stock's liquidity and investor engagement.

News

MEDICAL NUTRITION

CHRONIC DISEASES

GASTROINTESTINAL DISORDERS

PERSONALIZED NUTRITION

Aug 22, 2024

Global Medical Nutrition Market Size Anticipated to Surge Past USD 26,555.9 Million Valuation by 2034, Growing at an Average 6.4% CAGR | Future Market Insights, Inc.

GUARDION HEALTH SCIENCES

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024

PRESS RELEASES

May 31, 2024

Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution

PRESS RELEASES

May 23, 2024

Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business

PRESS RELEASES

May 13, 2024

Guardion Health Sciences Announces